How to cite item

Elevated HOTAIR expression associated with cisplatin resistance in non-small cell lung cancer patients

   
@article{JTD10563,
	author = {Ming-Yue Liu and Xi-Qing Li and Tian-Hui Gao and Yao Cui and Ning Ma and Yun Zhou and Guo-Jun Zhang},
	title = {Elevated HOTAIR expression associated with cisplatin resistance in non-small cell lung cancer patients},
	journal = {Journal of Thoracic Disease},
	volume = {8},
	number = {11},
	year = {2016},
	keywords = {},
	abstract = {Background: This study investigated the mechanism of drug resistance in non-small cell lung cancer (NSCLC) patients. We specifically studied whether long noncoding RNAs influence drug resistance in NSCLC to discover new therapeutic targets to increase the survival rate of drug-resistant NSCLC patients.
Methods: Tissue samples were collected from NSCLC patients, and total RNA was isolated for assessment of HOTAIR expression and drug resistance status. MTT assays, tumor sphere formation assays, and western blot were performed to cytologically determine the relationship between HOTAIR expression and cisplatin resistance, as well as to elucidate the potential molecular mechanism involved.
Results: HOTAIR expression in tissues of drug-resistant NSCLC patients was higher than that of non-drug-resistant patients. HOTAIR expression was elevated in cisplatin-resistant cell strains (A549/CDDP), and reducing HOTAIR expression increased the sensitivity of A549/CDDP cells to cisplatin. In addition, overexpression of HOTAIR in A549 cells increased resistance to cisplatin. Tumor sphere formation assays showed that the volume of spheres formed by cell strains expressing elevated levels of HOTAIR was greater than that of cell strains with low expression. Western blot experiments showed that elevated expression of HOTAIR upregulated tumor stem cell-related biomarkers and HOTAIR expression was directly related to Klf4 expression.
Conclusions: Elevated HOTAIR expression is associated with drug resistance in NSCLC patients and is related to Klf4 upregulation, providing a new therapeutic target for drug-resistant NSCLC patients.},
	issn = {2077-6624},	url = {https://jtd.amegroups.org/article/view/10563}
}